Sharon Shacham
2016
In 2016, Sharon Shacham earned a total compensation of $1.4M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 69% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $166,000 |
---|---|
Option Awards | $758,523 |
Salary | $415,000 |
Other | $11,260 |
Total | $1,350,783 |
Shacham received $758.5K in option awards, accounting for 56% of the total pay in 2016.
Shacham also received $166K in non-equity incentive plan, $415K in salary and $11.3K in other compensation.
Rankings
In 2016, Sharon Shacham's compensation ranked 6,771st out of 14,075 executives tracked by ExecPay. In other words, Shacham earned more than 51.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,771 | 52nd |
Manufacturing | 2,528 | 54th |
Chemicals And Allied Products | 822 | 57th |
Drugs | 631 | 59th |
Pharmaceutical Preparations | 498 | 58th |
Shacham's colleagues
We found three more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2016.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019